Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma In Situ of Breast
Yasuaki Sagara(Brigham and Women's Hospital), Masakazu Toi(Kyoto University)
Cited by 29
Related Papers
Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies
|British Journal of Cancer|2009|94
Prognostic significance of tumor/stromal caveolin‐1 expression in breast cancer patients
|Cancer Science|2011|62
Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy
|Breast Cancer Research and Treatment|2013|55